Literature DB >> 33850271

Pattern of inflammatory immune response determines the clinical course and outcome of COVID-19: unbiased clustering analysis.

Eunyoung Emily Lee1, Kyoung-Ho Song2, Woochang Hwang3, Sin Young Ham2, Hyeonju Jeong2, Jeong-Han Kim4, Hong Sang Oh4, Yu Min Kang5,6, Eun Bong Lee7, Nam Joong Kim8, Bum Sik Chin9, Jin Kyun Park10.   

Abstract

The objective of the study was to identify distinct patterns in inflammatory immune responses of COVID-19 patients and to investigate their association with clinical course and outcome. Data from hospitalized COVID-19 patients were retrieved from electronic medical record. Supervised k-means clustering of serial C-reactive protein levels (CRP), absolute neutrophil counts (ANC), and absolute lymphocyte counts (ALC) was used to assign immune responses to one of three groups. Then, relationships between patterns of inflammatory responses and clinical course and outcome of COVID-19 were assessed in a discovery and validation cohort. Unbiased clustering analysis grouped 105 patients of a discovery cohort into three distinct clusters. Cluster 1 (hyper-inflammatory immune response) was characterized by high CRP levels, high ANC, and low ALC, whereas Cluster 3 (hypo-inflammatory immune response) was associated with low CRP levels and normal ANC and ALC. Cluster 2 showed an intermediate pattern. All patients in Cluster 1 required oxygen support whilst 61% patients in Cluster 2 and no patient in Cluster 3 required supplementary oxygen. Two (13.3%) patients in Cluster 1 died, whereas no patient in Clusters 2 and 3 died. The results were confirmed in an independent validation cohort of 116 patients. We identified three different patterns of inflammatory immune response to COVID-19. Hyper-inflammatory immune responses with elevated CRP, neutrophilia, and lymphopenia are associated with a severe disease and a worse outcome. Therefore, targeting the hyper-inflammatory response might improve the clinical outcome of COVID-19.

Entities:  

Year:  2021        PMID: 33850271     DOI: 10.1038/s41598-021-87668-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  24 in total

Review 1.  Homeostasis, inflammation, and disease susceptibility.

Authors:  Maya E Kotas; Ruslan Medzhitov
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

Review 2.  How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy.

Authors:  Georg Schett; Dirk Elewaut; Iain B McInnes; Jean-Michel Dayer; Markus F Neurath
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

3.  New Statin Use and Mortality in Older Veterans.

Authors:  Ali Ahmed; Wen-Chih Wu; Charles Faselis
Journal:  JAMA       Date:  2020-11-10       Impact factor: 56.272

4.  Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis.

Authors:  Christopher W Seymour; Jason N Kennedy; Shu Wang; Chung-Chou H Chang; Corrine F Elliott; Zhongying Xu; Scott Berry; Gilles Clermont; Gregory Cooper; Hernando Gomez; David T Huang; John A Kellum; Qi Mi; Steven M Opal; Victor Talisa; Tom van der Poll; Shyam Visweswaran; Yoram Vodovotz; Jeremy C Weiss; Donald M Yealy; Sachin Yende; Derek C Angus
Journal:  JAMA       Date:  2019-05-28       Impact factor: 56.272

5.  Pregnancy rates and perinatal outcomes in women with systemic lupus erythematosus: data from the Korean national health claims database.

Authors:  Young Bin Joo; Ki-Jo Kim; Kyung-Su Park; Yune-Jung Park
Journal:  Clin Rheumatol       Date:  2020-11-12       Impact factor: 2.980

6.  The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19).

Authors:  Brandon Michael Henry; Stefanie W Benoit; Jens Vikse; Brandon A Berger; Christina Pulvino; Jonathan Hoehn; James Rose; Maria Helena Santos de Oliveira; Giuseppe Lippi; Justin L Benoit
Journal:  Clin Chem Lab Med       Date:  2020-11-26       Impact factor: 3.694

7.  Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activity.

Authors:  T W Kensler; C Erlichman; H N Jayaram; A K Tyagi; B Ardalan; D A Cooney
Journal:  Cancer Treat Rep       Date:  1980 Aug-Sep

8.  A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring.

Authors:  Ayelet Alpert; Yishai Pickman; Michael Leipold; Yael Rosenberg-Hasson; Xuhuai Ji; Renaud Gaujoux; Hadas Rabani; Elina Starosvetsky; Ksenya Kveler; Steven Schaffert; David Furman; Oren Caspi; Uri Rosenschein; Purvesh Khatri; Cornelia L Dekker; Holden T Maecker; Mark M Davis; Shai S Shen-Orr
Journal:  Nat Med       Date:  2019-03-06       Impact factor: 53.440

9.  Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.

Authors:  Evangelos J Giamarellos-Bourboulis; Mihai G Netea; Nikoletta Rovina; Karolina Akinosoglou; Anastasia Antoniadou; Nikolaos Antonakos; Georgia Damoraki; Theologia Gkavogianni; Maria-Evangelia Adami; Paraskevi Katsaounou; Maria Ntaganou; Magdalini Kyriakopoulou; George Dimopoulos; Ioannis Koutsodimitropoulos; Dimitrios Velissaris; Panagiotis Koufargyris; Athanassios Karageorgos; Konstantina Katrini; Vasileios Lekakis; Mihaela Lupse; Antigone Kotsaki; George Renieris; Danai Theodoulou; Vassiliki Panou; Evangelia Koukaki; Nikolaos Koulouris; Charalambos Gogos; Antonia Koutsoukou
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

10.  Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.

Authors:  Li Tan; Qi Wang; Duanyang Zhang; Jinya Ding; Qianchuan Huang; Yi-Quan Tang; Qiongshu Wang; Hongming Miao
Journal:  Signal Transduct Target Ther       Date:  2020-03-27
View more
  9 in total

Review 1.  SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.

Authors:  Julia Del Amo; Rosa Polo; Santiago Moreno; Inma Jarrín; Miguel A Hernán
Journal:  AIDS       Date:  2022-02-01       Impact factor: 4.177

2.  Preadmission Statin Treatment and Outcome in Patients Hospitalized With COVID-19.

Authors:  Marwan Saad; Kevin F Kennedy; David W Louis; Hafiz Imran; Charles F Sherrod; Karen Aspry; Amgad Mentias; Athena Poppas; J Dawn Abbott; Herbert D Aronow
Journal:  Am J Cardiol       Date:  2022-06-14       Impact factor: 3.133

3.  Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.

Authors:  Wolfgang Bauer; Marcus Weber; Eva Diehl-Wiesenecker; Noa Galtung; Monika Prpic; Rajan Somasundaram; Rudolf Tauber; Jochen M Schwenk; Patrick Micke; Kai Kappert
Journal:  Viruses       Date:  2021-12-07       Impact factor: 5.048

Review 4.  Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?

Authors:  Esther Y Bae; James M Sanders; Meagan L Johns; Kevin Lin; Jessica K Ortwine; Wenjing Wei; Norman S Mang; James B Cutrell
Journal:  Curr Infect Dis Rep       Date:  2021-12-11       Impact factor: 3.725

5.  Identification of Endotypes of Hospitalized COVID-19 Patients.

Authors:  Benjamin L Ranard; Murad Megjhani; Kalijah Terilli; Kevin Doyle; Jan Claassen; Michael R Pinsky; Gilles Clermont; Yoram Vodovotz; Shadnaz Asgari; Soojin Park
Journal:  Front Med (Lausanne)       Date:  2021-11-11

Review 6.  Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.

Authors:  Carlos A Labarrere; Ghassan S Kassab
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

Review 7.  Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus.

Authors:  Divya Narayanan; Tanyalak Parimon
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

Review 8.  Applying Lessons Learned From COVID-19 Therapeutic Trials to Improve Future ALI/ARDS Trials.

Authors:  Qun Wu; Meghan E Pennini; Julie N Bergmann; Marina L Kozak; Kristen Herring; Kimberly L Sciarretta; Kimberly L Armstrong
Journal:  Open Forum Infect Dis       Date:  2022-07-30       Impact factor: 4.423

9.  Predication of oxygen requirement in COVID-19 patients using dynamic change of inflammatory markers: CRP, hypertension, age, neutrophil and lymphocyte (CHANeL).

Authors:  Eunyoung Emily Lee; Woochang Hwang; Kyoung-Ho Song; Jongtak Jung; Chang Kyung Kang; Jeong-Han Kim; Hong Sang Oh; Yu Min Kang; Eun Bong Lee; Bum Sik Chin; Woojeung Song; Nam Joong Kim; Jin Kyun Park
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.